Business Context and Reporting Period
This Form 8-K is filed by Onconova Therapeutics, Inc. (not Traws Pharma, Inc., as indicated in the metadata) for the event date of September 25, 2023. The company is incorporated in Delaware and its common stock (Symbol: ONTX) is listed on The Nasdaq Capital Market.
Key Financial Metrics
This filing is a current report regarding listing compliance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The material event reported is the receipt of a notice from The Nasdaq Capital Market indicating the company failed to comply with the minimum bid price requirement under Listing Rule 5550(a)(2). The company's stock has traded below the required minimum closing bid price of $1.00 per share.
Outlook, Risks, and Management Commentary
- Compliance Period: The company has a 180-calendar-day grace period, ending March 25, 2024, to regain compliance.
- Compliance Criteria: To regain compliance, the common stock must maintain a minimum closing bid price of at least $1.00 per share for a minimum of ten consecutive business days during the grace period.
- Secondary Compliance Option: If not compliant by March 25, 2024, the company may be afforded a second 180-day period. This requires meeting the market value of publicly held shares and other initial listing standards, and potentially effecting a reverse stock split.
- Risks: There is no assurance the company will regain compliance. Failure to do so within the allotted periods may result in delisting.
- Management Action: The company intends to monitor the closing bid price and consider available options to resolve the noncompliance.
Investor Verification Checklist
- Verify the current trading price of ONTX to assess proximity to the $1.00 threshold.
- Monitor the company's stock price for ten consecutive business days to determine if the initial grace period compliance criteria are met.
- Review future filings for announcements regarding a potential reverse stock split if the initial grace period expires without compliance.
- Confirm the company's market value of publicly held shares to assess eligibility for a second compliance period.